Global Injectable Drug Delivery Systems Market Research Report 2024

Publication ID:

PB502251680

Publication Date:

February 28, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.

The global Injectable Drug Delivery Systems market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery Systems.

Report Scope

The Injectable Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Baxter

Becton, Dickinson

Gerresheimer

Pfizer

Schott

ELI Lilly

Novartis

Terumo

Teva Pharmaceutical

Novo Nordik

Segment by Type

Pre-filled Syringes

Auto-injectors (Syringe and Cartridge Based)

Pen Injectors

Others

Segment by Application

Hospitals & Clinics

Home Care

Others

Consumption by Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Injectable Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Injectable Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Injectable Drug Delivery Systems Market Overview

1.1 Product Overview and Scope of Injectable Drug Delivery Systems

1.2 Injectable Drug Delivery Systems Segment by Type

1.2.1 Global Injectable Drug Delivery Systems Market Value Comparison by Type (2024-2030)

1.2.2 Pre-filled Syringes

1.2.3 Auto-injectors (Syringe and Cartridge Based)

1.2.4 Pen Injectors

1.2.5 Others

1.3 Injectable Drug Delivery Systems Segment by Application

1.3.1 Global Injectable Drug Delivery Systems Market Value by Application: (2024-2030)

1.3.2 Hospitals & Clinics

1.3.3 Home Care

1.3.4 Others

1.4 Global Injectable Drug Delivery Systems Market Size Estimates and Forecasts

1.4.1 Global Injectable Drug Delivery Systems Revenue 2019-2030

1.4.2 Global Injectable Drug Delivery Systems Sales 2019-2030

1.4.3 Global Injectable Drug Delivery Systems Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Injectable Drug Delivery Systems Market Competition by Manufacturers

2.1 Global Injectable Drug Delivery Systems Sales Market Share by Manufacturers (2019-2024)

2.2 Global Injectable Drug Delivery Systems Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Injectable Drug Delivery Systems Average Price by Manufacturers (2019-2024)

2.4 Global Injectable Drug Delivery Systems Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Injectable Drug Delivery Systems, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Injectable Drug Delivery Systems, Product Type & Application

2.7 Injectable Drug Delivery Systems Market Competitive Situation and Trends

2.7.1 Injectable Drug Delivery Systems Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Injectable Drug Delivery Systems Players Market Share by Revenue

2.7.3 Global Injectable Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Injectable Drug Delivery Systems Retrospective Market Scenario by Region

3.1 Global Injectable Drug Delivery Systems Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Injectable Drug Delivery Systems Global Injectable Drug Delivery Systems Sales by Region: 2019-2030

3.2.1 Global Injectable Drug Delivery Systems Sales by Region: 2019-2024

3.2.2 Global Injectable Drug Delivery Systems Sales by Region: 2025-2030

3.3 Global Injectable Drug Delivery Systems Global Injectable Drug Delivery Systems Revenue by Region: 2019-2030

3.3.1 Global Injectable Drug Delivery Systems Revenue by Region: 2019-2024

3.3.2 Global Injectable Drug Delivery Systems Revenue by Region: 2025-2030

3.4 North America Injectable Drug Delivery Systems Market Facts & Figures by Country

3.4.1 North America Injectable Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Injectable Drug Delivery Systems Sales by Country (2019-2030)

3.4.3 North America Injectable Drug Delivery Systems Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Injectable Drug Delivery Systems Market Facts & Figures by Country

3.5.1 Europe Injectable Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Injectable Drug Delivery Systems Sales by Country (2019-2030)

3.5.3 Europe Injectable Drug Delivery Systems Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Injectable Drug Delivery Systems Market Facts & Figures by Country

3.6.1 Asia Pacific Injectable Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Injectable Drug Delivery Systems Sales by Country (2019-2030)

3.6.3 Asia Pacific Injectable Drug Delivery Systems Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Injectable Drug Delivery Systems Market Facts & Figures by Country

3.7.1 Latin America Injectable Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Injectable Drug Delivery Systems Sales by Country (2019-2030)

3.7.3 Latin America Injectable Drug Delivery Systems Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Injectable Drug Delivery Systems Market Facts & Figures by Country

3.8.1 Middle East and Africa Injectable Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Injectable Drug Delivery Systems Sales by Country (2019-2030)

3.8.3 Middle East and Africa Injectable Drug Delivery Systems Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Injectable Drug Delivery Systems Sales by Type (2019-2030)

4.1.1 Global Injectable Drug Delivery Systems Sales by Type (2019-2024)

4.1.2 Global Injectable Drug Delivery Systems Sales by Type (2025-2030)

4.1.3 Global Injectable Drug Delivery Systems Sales Market Share by Type (2019-2030)

4.2 Global Injectable Drug Delivery Systems Revenue by Type (2019-2030)

4.2.1 Global Injectable Drug Delivery Systems Revenue by Type (2019-2024)

4.2.2 Global Injectable Drug Delivery Systems Revenue by Type (2025-2030)

4.2.3 Global Injectable Drug Delivery Systems Revenue Market Share by Type (2019-2030)

4.3 Global Injectable Drug Delivery Systems Price by Type (2019-2030)

5 Segment by Application

5.1 Global Injectable Drug Delivery Systems Sales by Application (2019-2030)

5.1.1 Global Injectable Drug Delivery Systems Sales by Application (2019-2024)

5.1.2 Global Injectable Drug Delivery Systems Sales by Application (2025-2030)

5.1.3 Global Injectable Drug Delivery Systems Sales Market Share by Application (2019-2030)

5.2 Global Injectable Drug Delivery Systems Revenue by Application (2019-2030)

5.2.1 Global Injectable Drug Delivery Systems Revenue by Application (2019-2024)

5.2.2 Global Injectable Drug Delivery Systems Revenue by Application (2025-2030)

5.2.3 Global Injectable Drug Delivery Systems Revenue Market Share by Application (2019-2030)

5.3 Global Injectable Drug Delivery Systems Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Baxter

6.1.1 Baxter Corporation Information

6.1.2 Baxter Description and Business Overview

6.1.3 Baxter Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Baxter Injectable Drug Delivery Systems Product Portfolio

6.1.5 Baxter Recent Developments/Updates

6.2 Becton, Dickinson

6.2.1 Becton, Dickinson Corporation Information

6.2.2 Becton, Dickinson Description and Business Overview

6.2.3 Becton, Dickinson Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Becton, Dickinson Injectable Drug Delivery Systems Product Portfolio

6.2.5 Becton, Dickinson Recent Developments/Updates

6.3 Gerresheimer

6.3.1 Gerresheimer Corporation Information

6.3.2 Gerresheimer Description and Business Overview

6.3.3 Gerresheimer Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Gerresheimer Injectable Drug Delivery Systems Product Portfolio

6.3.5 Gerresheimer Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Corporation Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pfizer Injectable Drug Delivery Systems Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 Schott

6.5.1 Schott Corporation Information

6.5.2 Schott Description and Business Overview

6.5.3 Schott Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Schott Injectable Drug Delivery Systems Product Portfolio

6.5.5 Schott Recent Developments/Updates

6.6 ELI Lilly

6.6.1 ELI Lilly Corporation Information

6.6.2 ELI Lilly Description and Business Overview

6.6.3 ELI Lilly Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)

6.6.4 ELI Lilly Injectable Drug Delivery Systems Product Portfolio

6.6.5 ELI Lilly Recent Developments/Updates

6.7 Novartis

6.6.1 Novartis Corporation Information

6.6.2 Novartis Description and Business Overview

6.6.3 Novartis Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis Injectable Drug Delivery Systems Product Portfolio

6.7.5 Novartis Recent Developments/Updates

6.8 Terumo

6.8.1 Terumo Corporation Information

6.8.2 Terumo Description and Business Overview

6.8.3 Terumo Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Terumo Injectable Drug Delivery Systems Product Portfolio

6.8.5 Terumo Recent Developments/Updates

6.9 Teva Pharmaceutical

6.9.1 Teva Pharmaceutical Corporation Information

6.9.2 Teva Pharmaceutical Description and Business Overview

6.9.3 Teva Pharmaceutical Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Teva Pharmaceutical Injectable Drug Delivery Systems Product Portfolio

6.9.5 Teva Pharmaceutical Recent Developments/Updates

6.10 Novo Nordik

6.10.1 Novo Nordik Corporation Information

6.10.2 Novo Nordik Description and Business Overview

6.10.3 Novo Nordik Injectable Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Novo Nordik Injectable Drug Delivery Systems Product Portfolio

6.10.5 Novo Nordik Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Injectable Drug Delivery Systems Industry Chain Analysis

7.2 Injectable Drug Delivery Systems Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Injectable Drug Delivery Systems Production Mode & Process

7.4 Injectable Drug Delivery Systems Sales and Marketing

7.4.1 Injectable Drug Delivery Systems Sales Channels

7.4.2 Injectable Drug Delivery Systems Distributors

7.5 Injectable Drug Delivery Systems Customers

8 Injectable Drug Delivery Systems Market Dynamics

8.1 Injectable Drug Delivery Systems Industry Trends

8.2 Injectable Drug Delivery Systems Market Drivers

8.3 Injectable Drug Delivery Systems Market Challenges

8.4 Injectable Drug Delivery Systems Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

Companies Mentioned:

Baxter

Becton, Dickinson

Gerresheimer

Pfizer

Schott

ELI Lilly

Novartis

Terumo

Teva Pharmaceutical

Novo Nordik

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂